Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Current Liabilities (2016 - 2025)

Sanofi (SNY) has disclosed Total Current Liabilities for 11 consecutive years, with $33.0 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 5.88% to $33.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.0 billion through Dec 2025, up 5.88% year-over-year, with the annual reading at $32.0 billion for FY2025, 1.46% up from the prior year.
  • Total Current Liabilities hit $33.0 billion in Q4 2025 for Sanofi, up from $31.2 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $33.0 billion in Q4 2025 to a low of $24.4 billion in Q4 2021.
  • Historically, Total Current Liabilities has averaged $27.8 billion across 5 years, with a median of $26.0 billion in 2023.
  • Biggest five-year swings in Total Current Liabilities: increased 0.4% in 2022 and later increased 19.65% in 2024.
  • Year by year, Total Current Liabilities stood at $24.4 billion in 2021, then rose by 0.4% to $24.5 billion in 2022, then grew by 6.48% to $26.0 billion in 2023, then rose by 19.65% to $31.2 billion in 2024, then grew by 5.88% to $33.0 billion in 2025.
  • Business Quant data shows Total Current Liabilities for SNY at $33.0 billion in Q4 2025, $31.2 billion in Q4 2024, and $26.0 billion in Q4 2023.